Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503353
What this trial is testing

T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies

Who this might be right for
B Cell MalignanciesAcute Lymphobkastic LeukemiaNon-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
Sheba Medical Center 50
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12